| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-012-0840-0 |
| P698 | PubMed publication ID | 22855135 |
| P50 | author | Teresa Ramón Y Cajal | Q96057691 |
| P2093 | author name string | E Aranda | |
| C Guillén Ponce | |||
| P Pérez Segura | |||
| R Serrano Blanch | |||
| P2860 | cites work | Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene | Q24311652 |
| Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies | Q24647838 | ||
| Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene | Q24658271 | ||
| Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene | Q28249576 | ||
| Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series | Q28264132 | ||
| Early detection of pancreatic cancer: why, who, and how to screen | Q28295036 | ||
| Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c | Q28506197 | ||
| AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association | Q33783647 | ||
| Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma | Q34240299 | ||
| Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 | ||
| The diagnosis of pancreatic cancer | Q34372480 | ||
| Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders | Q34386474 | ||
| Very high risk of cancer in familial Peutz-Jeghers syndrome | Q34512286 | ||
| An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms | Q34549300 | ||
| Frequency and spectrum of cancers in the Peutz-Jeghers syndrome | Q34567595 | ||
| Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment | Q34568841 | ||
| Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. | Q34577777 | ||
| Age-conditional probabilities of developing cancer | Q34667627 | ||
| Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling | Q34694716 | ||
| A "catastrophic hypothesis" for pancreas cancer progression | Q35154553 | ||
| Elevated cancer mortality in the relatives of patients with pancreatic cancer | Q35308706 | ||
| Familial pancreatic carcinoma in Jews | Q35934053 | ||
| Advances in counselling and surveillance of patients at risk for pancreatic cancer | Q36023352 | ||
| Management strategies for patients with hereditary pancreatic cancer | Q36233596 | ||
| Familial pancreatic cancer syndromes | Q36456829 | ||
| PancPRO: risk assessment for individuals with a family history of pancreatic cancer | Q36495168 | ||
| A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. | Q36653283 | ||
| Molecular genetics of pancreatic intraepithelial neoplasia | Q36829524 | ||
| BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma | Q36854437 | ||
| Hereditary chronic pancreatitis | Q37061043 | ||
| Familial pancreatic cancer: a review and latest advances. | Q37064217 | ||
| Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes | Q37249683 | ||
| Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients | Q37249734 | ||
| Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis | Q37258392 | ||
| Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. | Q37352325 | ||
| An algorithmic approach to the diagnosis of pancreatic neoplasms | Q37406295 | ||
| Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients | Q37480736 | ||
| Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. | Q37988747 | ||
| Imaging of small pancreatic ductal adenocarcinoma. | Q41741524 | ||
| Advances in the early detection, diagnosis, and staging of pancreatic cancer | Q41759490 | ||
| DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease | Q41916266 | ||
| Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma. | Q41993538 | ||
| Familial association of benign pancreatic hyperenzymaemia and pancreatic cancer | Q42410025 | ||
| Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden | Q42690527 | ||
| Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. | Q43073144 | ||
| Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada | Q44116893 | ||
| Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging | Q44573382 | ||
| Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach | Q44957016 | ||
| The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in japan, using ca19-9 and elastase-1 or ultrasonography | Q45052294 | ||
| Accuracy of staging node-negative pancreas cancer: a potential quality measure | Q46500332 | ||
| Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population | Q47255748 | ||
| Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. | Q51155458 | ||
| Pancreatic cancer surveillance: learning as we go. | Q51572569 | ||
| Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. | Q53518654 | ||
| Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. | Q53539382 | ||
| Heterogeneity of risk for melanoma and pancreatic and digestive malignancies | Q57250703 | ||
| Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 | ||
| Update of Familial Pancreatic Cancer in Germany | Q57338212 | ||
| Update on Familial Pancreatic Cancer | Q57953769 | ||
| Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer | Q60609518 | ||
| Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study | Q68229428 | ||
| Clinical studies of multiple endocrine neoplasia type 1 (MEN1) | Q71777163 | ||
| Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group | Q72176250 | ||
| Screening and surveillance for hereditary pancreatic cancer | Q77149847 | ||
| The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1 | Q77687457 | ||
| Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer | Q78150758 | ||
| Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds | Q78763044 | ||
| BRCA2 germline mutations in familial pancreatic carcinoma | Q78891021 | ||
| Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds | Q79859526 | ||
| Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations | Q79887188 | ||
| Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis | Q81397407 | ||
| Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases | Q81580239 | ||
| Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups | Q81821222 | ||
| Multicentric pancreatic intraepithelial neoplasias (PanINs) presenting with the clinical features of chronic pancreatitis | Q82213710 | ||
| DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease | Q82310389 | ||
| Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families | Q82367104 | ||
| The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer | Q83982833 | ||
| P433 | issue | 8 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 553-563 | |
| P577 | publication date | 2012-07-19 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group | |
| P478 | volume | 14 |
| Q35138276 | Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. | cites work | P2860 |
Search more.